Additional bipolar indication for Seroquel

Seroquel and Seroquel XL (quetiapine) have been approved for the treatment of major depressive episodes in adults with bipolar disorder, in addition to the products' existing indications for schizophrenia and manic episodes. The new indication, for which the maximum daily dose is 600mg, carries a black triangle to indicate that all adverse events should
be reported.

View Seroquel drug record

Further information: AstraZeneca


To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

New opioid warnings and fentanyl patch contraindication

New opioid warnings and fentanyl patch contraindication

New warnings about tolerance and dependence are being...

NICE updates sciatica treatment guidance

NICE updates sciatica treatment guidance

Updated NICE guidance on sciatica advises against the...